,TE ,:ATU ,ORA     #A 
       ,H1L? ,NEW ,Z1L&

,TE ,K_AWANATANGA O ,AOTEAROA
    ,GOV]N;T ( ,NEW ,Z1L&

     ,,COVID-#AI ,VA39A;N

  ,"EY"O 9 ,AOTEAROA ,NEW
,Z1L& AG$ #E & OV] C GET A
FREE ,,COVID-#AI VA39E4

    ,:O C GET A ,,COVID-#AI
    VA39E
  ,"EY"O 9 ,AOTEAROA ,NEW
,Z1L& AG$ #E OR OV] C GET A
FREE ,,COVID-#AI VA39A;N4 ,X
DOES N MATT] :AT YR VISA OR
CITIZ5%IP /ATUS IS4
  ,*N AG$ #F MON?S TO #D YE>S
C GET ! 9FANT ,PFIZ] VA39E IF
!Y >E AT HI<] RISK ( SEV]E
ILL;S F ,,COVID-#AI4

                            #A
           VA39A;N        A#A 

    ,: VA39E Y W GET
  ,PFIZ] IS ! PREF]R$ ,,COVID-
#AI VA39E = USE 9 ,AOTEAROA
,NEW ,Z1L&4 ,WE USE ! ,PFIZ]
,,XBB#A4E MONOVAL5T VA39E4 ,?
IS AN UPDAT$ VA39E PRODUCES AN
IMMUNE RESPONSE AG/ ! ,OMICRON
SUBV>IANT1 ,,XBB4#A4E4
  ,PH>MAC HAS PREVI\SLY FUND$
A ,NOVAVAX VA39E = ,,COVID-
#AI4 ,H["E1 9 ,JULY #BJBD
,NOVAVAX )DREW XS APPLICA;N =
APPROVAL ( XS LATE/ VA39E4 ,!
,NOVAVAX VA39E IS "!=E
CURR5TLY UNAVAILABLE 9
,AOTEAROA ,NEW ,Z1L&4

    ,SIDE E6ECTS
  ,L MO/ M$IC9ES1 Y MI<T
EXP]I;E "S MILD SIDE E6ECTS 9
! "DS AF GETT+ YR VA39E4 ,? IS
COMMON1 & A SIGN T YR BODY IS
LE>N+ TO FI<T ! VIRUS4      #B
           VA39A;N        B#A 
  ,MO/ SIDE E6ECTS D N LA/ L;G
& W N /OP Y F HAV+ AN ADDI;NAL
DOSES OR GO+ AB YR DAILY LIFE4
  ,! MO/ COMMON REPORT$
REAC;NS >E3

_4 PA9 OR SWELL+ AT ! 9JEC;N
  SITE
_4 FEEL+ TIR$ OR FATIGU$
_4 H1DA*E
_4 MUSCLE A*ES
_4 *ILLS
_4 DIZZI;S
_4 SWOLL5 LYMPH NODES
_4 JO9T PA9
_4 F"E
_4 R$;S AT ! 9JEC;N SITE
_4 NAUSEA4

  ,IF Y H *E/ 4COM=T1 3TACT A
H1L?C>E PROVID] 9 CASE X IS A
SIGN ( "S?+ M S]I\S4
  ,"S SIDE E6ECTS >E M S]I\S B
R>E1 S* Z A SEV]E ALL]GIC   #C
           VA39A;N        C#A 
REAC;N4
  ,S]I\S ALL]GIC REAC;NS OR
ANAPHYLAXIS F ! VA39E >E R>E4
,? IS :Y P >E WAT*$ = >.D #AE
M9UTES PO/-VA39A;N4 ,VA39ATORS
>E WELL TRA9$ 9 MANAG+ ^! IF
!Y O3UR4
  ,M "<NON-TRANSLAT$"> 9=MA;N
ON ,,COVID-#AI SIDE E6ECTS &
REAC;NS3 HTTPS3_/_/T9YURL4"
COM_/YJ#C;D#C;DXE

    ,ADDI;NAL DOSES
  ,HAV+ ,,COVID-#AI DOES N
PROVIDE ! SAME LEVEL ( IMMUN;Y
Z GETT+ VA39AT$4 ,WE AL "K T
YR PROTEC;N F ! VA39E DECR1SES
OV] "T4
  ,TO KEEP YR IMMUN;Y LEVELS
HI<1 /AY UP TO DATE ) YR
IMMUNISA;NS,-9CLUD+ ADDI;NAL
DOSES4 ,? W L[] YR *.ES (
GETT+ V SICK F ,,COVID-#AI &
5D+ UP 9 HOSPITAL4          #D
           VA39A;N        D#A 

      ,IF Y >E #CJ YE>S ( AGE
      & OV]
  ,IF Y >E #CJ YE>S ( AGE &
OV]1 Y C H ADDI;NAL DOSES
REG>D.S ( ! NUMB] ( ,,COVID-
#AI VA39ES Y H ALR _H4
  ,Y C H AN ADDI;NAL DOSE IF Y
H _H YR 9ITIAL ,,COVID-#AI
VA39A;NS "<YR PRIM>Y C\RSE">4
  ,X IS RECOMM5D$3

_4 Y WAIT AT L1/ #F MON?S S9CE
  Y _H ,,COVID-#AI1 &2
_4 AT L1/ #F MON?S S9CE Y _H
  ANY O!R ,,COVID-#AI VA39E4

      ,IF Y >E #AF TO #BI YE>S
      ( AGE
  ,H1L?Y P AG$ #AF TO #BI C H
#A ADDI;NAL DOSE4
  ,TO GET AN ADDI;NAL DOSE3

_4 Y M/ H _H AT L1/ YR      #E
           VA39A;N        E#A 
  9ITIAL ,,COVID-#AI VA39A;NS
  "<PRIM>Y C\RSE">1 &2
_4 X IS RECOMM5D$ Y WAIT AT
  L1/ #F MON?S S9CE YR LA/
  ,,COVID-#AI VA39E OR 9FEC;N4

  ,"S P AG$ #AF TO #BI C H
ADDI;NAL DOSES4 ,? 9CLUDES3

_4 SEV]ELY IMMUNOCOMPROMIS$ P
_4 PREGNANT P
_4 ^? :O H A M$ICAL 3DI;N T
  9CR1SES ! RISK ( SEV]E ILL;S
  F ,,COVID-#AI
_4 ^? :O LIVE ) 4ABIL;Y )
  SIGNIFICANT OR COMPLEX H1L?
  NE$S OR MULTIPLE
  COMORBIDITIES4

      ,IF Y >E #AB TO #AE YE>S
      OLD
  ,H1L?Y RANGATAHI "<"Y P">
AG$ #AB TO #AE >E N ELIGIBLE =
ADDI;NAL DOSES4             #F
           VA39A;N        F#A 
  ,RANGATAHI AG$ #AB TO #AE :O
H A M$ICAL 3DI;N T 9CR1SES !
RISK ( SEV]E ILL;S F ,,COVID-
#AI C GET ADDI;NAL DOSES4
,TALK TO YR DOCTOR1 NURSE1 OR
H1L?C>E PROVID] AB :E!R ? IS
RECOMM5D$4

      ,*N "U #AB YE>S OLD
  ,H1L?Y TAMARIKI "<*N"> "U !
AGE ( #AB _C GET ADDI;NAL
DOSES4 ,*N H A GD IMMUNE
RESPONSE & >E M* LESS LIKELY
TO H A SEV]E ILL;S & NE$ TO G
TO HOSPITAL IF !Y GET ,,COVID-
#AI4
  ,AT RISK & IMMUNOCOMPROMIS$
TAMARIKI >E ELIGIBLE = !
,,COVID-#AI VA39E & MAY NE$ M
?AN #A DOSE ( ! VA39E TO 2
PROTECT$ F S]I\S ILL;S4 ,Y C
TALK TO YR DOCTOR1 NURSE OR
H1L?C>E PROVID] AB YR *'S
SPECIFIC CIRCUM/.ES4        #G
           VA39A;N        G#A 

    ,H[ TO BOOK A VA39A;N
      ,BOOK OV] ! PH"O
  ,BOOK OR ASK "QS OV] ! PH"O
F #H4CJ;AM TO #EPM1 ,MON"D TO
,FRI"D "<EXCEPT PUBLIC
HOLI"DS">4
  ,9T]PRET]S >E AVAILABLE & Y
C *OOSE TO SP1K ) A ,M_AORI
ADVISOR1 A 4ABIL;Y ADVISOR1 OR
USE ,,NZ ,RELAY4
  ,CALL3 #JHJJ"BH"BI"BF

      ,BOOK ONL9E
  ,X IS FREE1 FA/ & EASY TO
BOOK OR *ANGE YR APPO9T;TS US+
! WEBSITE ,BOOK A VA39E
"<9FO4H1L?4NZ">4
  ,2F Y BOOK1 *ECK ! APPO9T;T
AVAILABIL;Y MAP4 ,X C %[ Y ":
VA39A;N SITES >E1 H[ SOON Y C
GET AN APPO9T;T1 & : VA39E
TYPES >E AVAILABLE4
                            #H
           VA39A;N        H#A 

      ,BOOK "? YR USUAL
      H1L?C>E PROVID]
  ,CALL YR USUAL DOCTOR1
NURSE1 OR H1L?C>E PROVID]1 IF
Y H "O1 TO MAKE AN IMMUNISA;N
APPO9T;T4 ,PLAN AT L1/ #A TO
#B WEEKS AH1D S Y C GET A "T &
DATE T "WS BE/ = Y & YR
:_ANAU4

      ,WALK 9S
  ,"! >E _M PLACES >.D ,NEW
,Z1L& ": Y C GET A ,,COVID-#AI
VA39E )\T AN APPO9T;T4
  ,TO F9D \ ": Y C A3ESS
VA39A;N PROVID]S1 SEE
,H1L?PO9T "<HTTPS3_/_/T9YURL4"
COM_/YFXH#F;C#EC">4
"<,! 9=MA;N ON ! L9K ABV MAY N
2 AVAILABLE 9 ALT]NATE =MATS">
,IF Y NE$ SUPPORT

_4 ,! ,,COVID-#AI           #I
           VA39A;N        I#A 
  ,4ABIL;Y ,HELPL9E C PROVIDE
  HELP OR 9=MA;N AB VA39ES1
  FACE MASK EXEMP;NS1 TE/+1
  MANAG+ ,,COVID-#AI1 & ANY
  O!R H1L? 3C]NS Y MAY H4 ,A
  P]SON ) EXP]I;E OR K (
  4ABIL;Y W ANSW] YR CALL
  #H;AM-#FPM ,MON"D TO ,FRI"D4
  _4 ,CALL #JHJJ"AA"AB"AC =
    FREE4
  _4 ,IF Y >E UNABLE TO CALL1
    Y C TEXT #HIHH1 OR2
  _4 EMAIL A3ESS@A"
    :AKARONGORAU4NZ4
_4 ,Y C AL CALL ,H1L?L9E =
  FREE CL9ICAL ADVICE ON
  #JHJJ"FAA"AAF4

    ,IF Y NE$ SUPPORT
_4 ,! ,,COVID-#AI 4ABIL;Y
  HELPL9E C PROVIDE HELP OR
  9=MA;N AB VA39ES1 TE/+1
  MANAG+ ,,COVID-#AI1 & ANY
  O!R H1L? 3C]NS Y MAY     #AJ
           VA39A;N        J#A 
  H4
  ,CALL #JHJJ"AA"AB"AC = FREE4
  ,IF Y >E UNABLE TO CALL1 Y C
  TEXT #HIHH4
_4 ,Y C AL CALL ,H1L?L9E =
  FREE = ADVICE ON
  #JHJJ"FAA"AAF4

,PRODUC$ #BJBD BY
,A3ESSIBLE ,=MATS ,S]VICE
,BL ,L[ ,VI.N ,,NZ1 ,AUCKL&1
  ,NEW ,Z1L&

           ,,! ,,5D









                           #AA